NSC-768684

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNSC-768684
Drug Alias Nametriazole-vanillin molecular hybrids (Leidos Biomedical Research)NSC-768688NSC-768684
ClassificationSmall molecules
Mechanisms of ActionInhibitor of apoptosis protein 3 inhibitors
TargetsInhibitor of apoptosis protein 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeidos Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeidos Biomedical Research Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A